£3.3M
The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.
M
MicrofluidX
MicrofluidX provides next-generation bioreactors for cell research and manufacturing.
£4.7MTotal raised
MicrofluidX develops next-generation bioreactors and scalable cell culture platforms for advanced research and manufacturing.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from MicrofluidX's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
AE
Antoine Espinet
CEO
Investors
- £3.3M
- £1.4M
Funding history
£1.4M
The seed round was led by UKI2S and Longwall Ventures to support cell therapy bioprocessing development.